Zaks Tal Zvi

SEC Form 4 insider trading activity

Zaks Tal Zvi has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.

On the most recent filing, Zaks Tal Zvi is listed as Director at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Zaks Tal Zvi reported no open-market purchases and 1 open-market sale totaling $593 in TEVA.

Companies traded

Other insiders at TEVA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$593

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TEVA
Zaks Tal Zvi
Sale$593Aug 10SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Zaks Tal Zvi made?

Zaks Tal Zvi has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Zaks Tal Zvi trade?

Zaks Tal Zvi has filed SEC Form 4 disclosures for 1 company, including TEVA.

When was Zaks Tal Zvi's most recent SEC Form 4 filing?

Zaks Tal Zvi's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.

What is Zaks Tal Zvi's total buy and sell value in the current window?

Inside the rolling retention window, Zaks Tal Zvi bought $0 and sold $593 based on SEC Form 4 filings.

What was Zaks Tal Zvi's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 17 TEVA shares on 2026-08-05, worth $593, per SEC Form 4 filings.